NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/04/2024
Back to search
Official data from USPTO
IMMUNEACCESS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNEACCESS
ST13
US500000087190390Class
42
Filing
87190390
Registration
5331111
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/04/2024
Trademark type
Word
Nice classes
42
Filing date
10/01/2016
Registration date
11/07/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2024
Last transaction
05/04/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/25/2016
First use in commerce
10/25/2016
Drawing code
4
Owner type
03
Owner location
Seattle, WA
Examiner
HARDY LUDLOW, TARAH
Law office
M10
Current location
TMO LAW OFFICE 110
Holders and representatives
Holders
A. C. (pessoa física)
Representatives
Hoang-chi Truong Patent Law Works LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Computer servicesproviding on-line non-downloadable computer software for access to and analysis of the data and information in the fields of immunologymedicineimmune-related diseases and immune repertoire sequencing; computer servicesproviding an interactive online portal that allows users to search datashare dataanalyze datacollaborate with others for scientific research and discovery in the fields of immunologymedicineimmune-related diseases and immune repertoire sequencing; computer databases for use in electronic storage and analysis of immune repertoire sequencing data for use in the fields of immunologymedicineimmune-related diseases and immune repertoire sequencing; providing an online database featuring sequencing data and information about adaptive immune receptor sequences for use in scientific or medical research
Publications
History of USPTO decisions and trademark events.
32 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/03/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/06/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/13/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/03/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/02/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/30/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/29/2017
IUAF
USE AMENDMENT FILED
09/19/2017
EISU
TEAS STATEMENT OF USE RECEIVED
09/19/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/04/2017
CHPB
POST PUBLICATION AMENDMENT - ENTERED
07/02/2017
APET
ASSIGNED TO PETITION STAFF
06/29/2017
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
06/27/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/09/2017
PUBO
PUBLISHED FOR OPPOSITION
05/09/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/19/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/30/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
03/30/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/30/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
03/30/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/30/2017
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
01/14/2017
GPRA
PRIORITY ACTION E-MAILED
01/14/2017
CPRA
PRIORITY ACTION WRITTEN
01/14/2017
DOCK
ASSIGNED TO EXAMINER
01/10/2017
MPMK
NOTICE OF PSEUDO MARK E-MAILED
10/07/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2016
NWAP
NEW APPLICATION ENTERED
10/05/2016
Continuous trademark protection
Get notified about every new filing that threatens IMMUNEACCESS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.